Introduction: Since shrinkage of lesions in patients with metastatic hepatic neuroendocrine neoplasm (MHNEN) receiving systemic therapy is rarely observed,limit of RECIST for evaluating treatment response gradually emerged.
Aim(s): To investigate the feasibility of parametric contrast-enhanced ultrasound (CEUS) for early therapeutic response evaluation.
Materials and methods: 13 MHNEN patients who received systemic therapy underwent baseline ultrasound,2D-CEUS and 3D-CEUS pre-treatment and post-treatment regularly(after 1/2,1,2 and 3 period of treatment).CEUS raw data was analyzed to render time-intensity curve and extract parameters:peak intensity(PI),area under curve(AUC) and slope.Treatment response was assessed with CECT according to RECIST.Relation between percentage of parameters changed (Δparameter%) and response,distinction between 2D and 3D-CEUS were analyzed.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: house physician Xiaona Lin
To read results and conclusion, please login ...
Further abstracts you may be interested in